Introduction {#S0001}
============

It is well-established that tobacco use is the leading cause of the global Chronic Obstructive Pulmonary Disease (COPD) burden,[@CIT0001] and that smoking needs to be urgently addressed well in advance of a COPD diagnosis.[@CIT0002] In the Eastern Mediterranean region, where the prevalence of smoking is particularly high,[@CIT0003] there has been a dramatic increase in the reported numbers of COPD cases.[@CIT0004] The region also has witnessed a rise in waterpipe (WP) smoking, and the latter is now the most common form of tobacco used among youth in the region.[@CIT0005] This epidemic warrants concern given the toxicant profile of WP smoke,[@CIT0006],[@CIT0007] and its association with respiratory diseases such as chronic bronchitis, COPD, and lung cancer.[@CIT0008]--[@CIT0010]

Respiratory symptoms are now acknowledged to be sensitive indicators of smoking-induced airway disease.[@CIT0002],[@CIT0011],[@CIT0012] In young adulthood in particular, respiratory symptoms are important because wide variations in lung volume can deter airway disease diagnosis using conventional spirometry.[@CIT0012] In fact, subjects with respiratory symptoms have been compared to those with mild-to-moderate airflow obstruction and COPD in terms of medical management.[@CIT0002] In animal studies, chronic exposure to WP has been shown to cause alveolar damage and airspace expansion, and to prompt an inflammatory airway response.[@CIT0013]--[@CIT0015] Consistent with these preclinical studies, studies evaluating the respiratory health effects of WP specifically in young users have associated WP smoking with early onset of damage and with the occurrence of respiratory symptoms.[@CIT0016]--[@CIT0019] However, these studies, while useful and indicate detrimental chronic respiratory and health effects of WP use, were limited in size and varied in their definitions of WP exposure. For example, Hawari et al compared respiratory symptoms (phlegm, shortness of breath, cough, chest illnesses, coughing and phlegm episodes, colds, wheezing) as well as various cardiopulmonary measures in 69 habitual (regular), exclusive young male WP users relative to 69 non-smokers;[@CIT0016] Walters et al compared epigenetic changes (DNA methylation of the small airway epithelium) in 7 light, exclusive WP smokers to 7 non-smokers;[@CIT0017] Husain et al studied peak expiratory flow rates, asthma, frequency of respiratory infections, persistent cough, shortness of breath, and chest pain in 525 male students; and although roughly 46% were smokers, only 52 of the 525 were exclusive WP smokers and reported variable smoking habits (from less than once a week to daily);[@CIT0018] finally, Strulovici-Barel et al compared 19 non-smokers and 21 light, exclusive WP users to assess cough, sputum production, lung function, and various biological respiratory measures.[@CIT0019]

Supplementing the above-mentioned studies with well-controlled and sufficiently powered research can be of value in confirming the respiratory harms induced by exclusive WP use, specifically among young, exclusive WP smokers with comparable exposure.

This research builds on a previously conducted pilot study about the detrimental respiratory health effects of exclusive habitual WP smoking in young WP users.[@CIT0016] We sought to confirm the respiratory outcomes of WP use from our pilot study on a larger scale across four Arab countries (Egypt, Jordan, Morocco and Oman) as well as compare respiratory measures between WP and cigarette smokers, and whether or not differences in health-related quality of life also existed, given the evidence suggesting WP use negatively impacted quality of life in young users.[@CIT0020]--[@CIT0022] We included both cigarette smokers and non-smokers as positive and negative controls to benchmark our WP results. We hypothesized that young, habitual WP-only smokers would report more respiratory symptoms and poorer overall quality of life than never-smokers; and that WP smokers would be comparable to cigarette-only smokers in respiratory and quality of life measures.

There is a misperception among WP users that it is a safer tobacco product \[than the cigarette\].[@CIT0023] Smokers, particularly if young, may feel far-removed from severe diseases.[@CIT0024]--[@CIT0026] Thus, demonstrating through a larger study the respiratory harms of WP use in young adults can enable tobacco control experts to present more compelling evidence about the harms of WP in a context that is directly relevant to this age demographic, particularly when tied to the prognostic value of respiratory symptoms. Otherwise, young adults remain liable to believing that WP is safe to use while young, or is only harmful in a context (in terms of time, age group and disease) that does not apply to them.

Materials and methods {#S0002}
=====================

Ethical review {#S0002-S2001}
--------------

This study was approved by the Institutional Review Board at King Hussein Cancer Center (Jordan); and by research regulatory bodies at Ain Shams University (Egypt), Sidi Mohamed Ben Abdellah University (Morocco), and Sultan Qaboos University (Oman). All adult participants provided verbal consent to participate in this study because the research presented no more than minimal risk to the participants and did not involve procedures for which written consent is normally required outside of the research context.

Setting and sample {#S0002-S2002}
------------------

The study was conducted in four university campuses in Cairo (Egypt), Amman (Jordan), Fez (Morocco), and Muscat (Oman) using students as subjects. Purposive sampling was performed in order to recruit students who, similar to our previous research,[@CIT0016],[@CIT0027] were aged at least 18 years and not more than 27; did not suffer from any chronic health conditions (ie cardiovascular or lung disease including asthma and allergies; liver disease; kidney disease; and diabetes); and were either non-smokers; regular WP smokers who smoked at least three WP sessions a week for the past three years at least;[@CIT0016] or regular cigarette smokers who smoked at least five cigarettes a day for the past three years at least. According to Shafagoj et al.,[@CIT0028] the nicotine level of someone who smokes one WP/day is comparable to the plasma nicotine level of someone who smokes 10 cigarettes/day. Using these estimates, our WP smokers would be smoking the equivalent of 0.43 WP/day. Based on the rough equivalence of one WP/day to 10 cigarettes/day, 0.43 WP/day was therefore considered equivalent to 4.3 (approximately five) cigarettes/day. This is consistent with the rough (and cautious) equivalence of 10 cigarettes to a 45 min WP session which Jawad et al propose.[@CIT0029] We therefore included smokers who smoked at least five cigarettes daily (for the past three years at least).

Dual (both cigarette and WP) users, users of other forms of tobacco, and ex-smokers were excluded from the study.

Study design {#S0002-S2003}
------------

We employed a cross-sectional survey-based study design. Data collection lasted from January 2017 to July 2018. Trained data collectors in each country were responsible for screening and recruiting students, and for administering one part of the questionnaire (the respiratory symptoms section). The remainder of the survey was self-administered.

Sample size: Power and Sample Size Calculations software Version 3.1.2 was used to calculate the required sample size.[@CIT0030] The effect size was based on available studies regarding tobacco use and its association with respiratory symptoms and quality of life.[@CIT0016],[@CIT0020] Accordingly, we assumed that the proportion of WP users reporting cough or phlegm to be 14--18% higher than the proportion reporting these in non-smokers; and that the overall quality of life score would be roughly ten points lower in WP smokers than non-smokers. A type I error rate of 5% and a power of 80% were used. A case:control ratio of 1:3 was used to improve the overall power of the study. We calculated an overall sample size of 630 subjects: 270 exclusive cigarette smokers, 270 never-smokers and 90 exclusive WP smokers. We also oversampled due to the possibility of incomplete data entry. Finally, to ensure a sufficient number of exclusive habitual WP users could be reached, the overall sample was planned to be across the four countries (45% from Jordan, 25% from Egypt, 20% from Morocco and 10% from Oman). This distribution was based on the prevalence of WP smoking in each one of the countries,[@CIT0031],[@CIT0032] as well as the population density in these countries.

Variables and measurement instrument {#S0002-S2004}
------------------------------------

This study assessed the association between smoking status (non-smoker; regular WP smoker; regular cigarette smoker) and two outcomes of interest: general respiratory symptoms and quality of life; while adjusting for other lifestyle factors that may have influenced respiratory health and quality of life. Accordingly, the survey was composed of four sections:

Section measuring tobacco-related practices and knowledge: Cigarette smoking patterns (age of initiation, years of smoking; daily cigarette consumption; and intention to quit) and WP smoking patterns (age of initiation, years of smoking, WP sessions per week, WP heads per session, type of WP typically smoked (flavored or not), whether or not the WP was usually shared; locations where WP smoking usually took place; and intention to quit in the next month, six months, or not at all) were measured. For all students, tobacco-related knowledge of cigarette and WP harm ("do you think WPs are harmful?"; "do you think cigarettes are harmful?"; "do you think WP is more/less/similar in harm when compared to the cigarette"); and exposure to secondhand smoke and censer smoke (daily, few times a week, few times a month, never) were measured.

Respiratory symptoms section: This was largely based on questions related to general respiratory symptoms in the European Community Respiratory Health Survey II (questions 1 through 12, covering wheezing, coughing, shortness of breath, phlegm production, chest illnesses and difficulty breathing).[@CIT0033] Two additional questions were included from the American Thoracic Society and the Division of Lung Diseases, ATS-DLD-78 questionnaire:[@CIT0034] a question about cough accompanied by phlegm, and a question about colds and chest illness).

Quality of life section: Although the Short Form (SF) 36 was piloted for the study, students' complaints about the length of the survey rendered the SF-12 more practical, and it was therefore used in the final tool to elicit and compare quality of life scores (physical functioning; role-physical; bodily pain; general health; vitality; social functioning; role-emotional; and mental health) across groups.[@CIT0035]--[@CIT0038]

Section covering academic and sociodemographic characteristics (gender, age, marital status, college year, academic performance, and pocket money); and lifestyle characteristics such as diet, exercise, body mass index (BMI): Academic performance was measured categorically (Distinction, Excellent, Very good, Good, Acceptable, Fail). Pocket money was measured categorically using cut-offs relevant to each country, and standardized to create three groups: low pocket money group, middle pocket money group, and high pocket money group. Seven items were used to briefly measure diet and physical activity.[@CIT0039],[@CIT0040] Specifically, students were asked to report the frequency of strenuous activity they performed (ranging from daily to once a month or less) per week or month, as well as the number of hours (per week) they were engaged in strenuous activity. Students were also asked to report their intake of fruits, vegetables, fish, and sweets (ranging from daily to once a week or less).

Statistical analysis {#S0002-S2005}
--------------------

Descriptive bivariate analyses were conducted to compare WP smokers, cigarette smokers and non-smokers across respiratory symptoms, quality of life scores, and lifestyle-related practices and academic achievement. Chi square statistics were run to test for bivariate distributional differences in categorical variables across tobacco groups. With regards to differences in normally-distributed continuous variables across tobacco groups, independent *t*-tests (if comparing two groups) and ANOVA (one-way and pairwise) were used to measure bivariate distributional differences. Mann-Whitney and Kruskal-Wallis tests were used if the continuous variable failed the normality assumption. Šidák-Holm adjusted *p*-values also were generated.[@CIT0041],[@CIT0042]

Multivariable regressions were run to compare the rates of respiratory symptoms between WP smokers and non-smokers and cigarette smokers and non-smokers. We adjusted for factors that were relevant to respiratory health in general (and were significantly associated with tobacco use at a bivariate level). Specifically, a negative binomial regression model was used to model the count of respiratory symptoms across groups (controlling for second hand smoking exposure, censer smoke exposure, living near a factory, being overweight or obese, and leading an active lifestyle). Finally, logistic regressions were used to estimate the likelihood of specific respiratory symptoms (such as cough or phlegm) occurring in WP smokers and cigarette smokers (versus non-smokers) after multivariable adjustment.

Results {#S0003}
=======

Descriptive results {#S0003-S2001}
-------------------

The final sample was composed of 135 WP smokers, 303 cigarette smokers, and 300 non-smokers. Either tobacco group was composed of significantly greater proportions of males than the non-smoker group.

Tobacco use patterns for WP and cigarette smokers are displayed in [Table 1](#T0001){ref-type="table"}. Roughly 72% of WP smokers in the sample smoked between three and six sessions weekly, while approximately 71% of cigarette smokers smoked five to 20 cigarettes daily. A significantly greater proportion of cigarette smokers than WP smokers reported past quit attempts, with cigarette smokers reporting a greater average number of past quit attempts. More cigarette smokers than WP smokers also were planning to quit smoking in the next one to six months.Table 1Descriptive tobacco-related measures among waterpipe (WP), cigarette and non-smokersWP smokers (N=135)Cigarette smokers (N=303)Non-smokers (N=300)Between-group comparisons\***Mean age in years (median, standard deviation)**21.5 (21.4, 1.8)21.7 (21.5, 1.99)21.6 (21.6, 1.99)No significant overalldifference (*p*=0.77)**Gender, % male**70.9%95.0%50.3%WP vs NS (*p*=0.000)\
WP vs CS (*p*=0.000)\
CS vs NS (*p*=0.000)**Age of initiation of tobacco use in years, (median, standard deviation)**16.3 (16.5, 2.4)15.7 (16.0, 2.8)--No significant overalldifference (*p*=0.058)**Weekly sessions of WP** **3--4**47.4%---- **5--6**24.8%---- **7--8**13.5%----- **9--10**6.8%---- **\>10**7.5%----**WP session length** **\<30 min**12.6%---- **30--60 min**53.3%---- **61--90 min**19.3%----- **91--120 min**6.7%---- **\>120 min**8.2%----**WP heads per session** **\<1**19.6%---- **1--2**61.7%----- **3--4**15.0%---- **\>4**3.8%----**Proportion usually share WP**67.6%----**Daily cigarettes** **≤10**--27.7%-- **11--20**--43.2%-- **21--30**--17.2%--- **31--40**--6.3%-- **\>40**--5.6%--**Ever attempted to quit**50.4%72.5%--*p*=0.000**Average number quit attempts (median,standard deviation)**0.41 (0, 0.96)1.6 (0.2, 0.98)--*p*=0.001**Intention to quit within 1--6 months**25.2%44.6%--*p*=0.001**Daily secondhand smoke exposure**65.2%61.4%38.7%WP vs NS (*p*=0.000)\
CS vs NS (*p*=0.000)\
WP vs CS (*p*=0.450)**Daily censer smoke exposure**12.6%9.6%11.0%**Cigarettes perceived harmful (yes)**93.3%86.1%93.3%WP vs CS (*p*=0.03) CS vs NS (*p*=0.004)**WP perceived harmful (yes)**81.5%83.2%96.0%WP vs NS (*p*=0.000)\
CS vs NS (*p*=0.000)\
WP vs CS (*p*=0.670)**WP perceived relative harm: less harmful than cigarettes**35.6%13.2%8.3%WP vs NS (*p*=0.000)\
CS vs NS (*p*=0.054) WP vs CS (*p*=0.000)**WP perceived relative harm: more harmful than cigarettes**37.0%53.8%65.7%WP vs NS (*p*=0.000)\
CS vs NS (*p*=0.003) WP vs CS (*p*=0.001)**Country** **Jordan**46%45%46%No significant overall difference (*p*=0.80) **Egypt**25%27%22% **Morocco**17%17%18% **Oman**12%11%13%[^1]

With regards to tobacco-related variables, non-smokers were significantly less likely to be exposed to secondhand smoke than either group of smokers. Although the majority (\>80%) of the sample agreed that both WP and cigarettes were harmful, differences were observed with regards to perceived relative harm of the WP when compared to the cigarette. For example, significantly more WP smokers (than cigarette smokers or non-smokers) believed the WP was less harmful than the cigarette (35.6% of WP smokers, versus 13.2% and 8.3% of cigarette smokers and non-smokers, respectively).

With regards to academic and lifestyle-related characteristics of the sample ([Table 2](#T0002){ref-type="table"}), non-smokers had a significantly lower BMI than either group of smokers. Non-smokers also were less likely to engage in regular intake of sugar (than either group of smokers). Non-smokers were significantly less likely to fall in the highest category of monthly pocket money spent. Finally, a significantly higher proportion of non-smokers (than WP and cigarette smokers) reported an academic ranking of "very good" or higher (48.0% of non-smokers versus 32.6% in WP smokers and 30.0% in cigarette smokers).Table 2Descriptive lifestyle and academic characteristics of the sample (column percentages reported)Waterpipe smokers (N=135)Cigarette smokers (N=303)Non-smokers (N=300)Between-group comparisons\*Body mass index: mean (median, standard deviation)24.3 (23.7, 3.9)24.2 (23.6, 4.1)22.9 (22.4, 3.5)WP vs NS (*p*=0.0003) CS vs NS (*p*=0.0001)Eating vegetables atleast once a day52.6%47.5%50.3%No significant overall difference (*p*=0.59)Eating fruits atleast once a day58.5%48.5%47.0%No significant overall difference (*p*=0.07)Eating fish atleast twice a week20.7%22.8%19.0%No significant overall difference (*p*=0.52)Eating sugary snacks, sodas or chips daily68.2%61.7%49.3%WP vs NS (*p*=0.000)\
CS vs NS (*p*=0.002)Eating breakfast daily or almost daily54.8%55.8%64.3%No significant overall difference (*p*=0.055)Regular exercising^¶^25.9%36.0%30.0%No significant overall difference (*p*=0.13)Academic rank "very good" or higher32.6%30.0%48.0%WP vs NS (*p*=0.003)\
CS vs NS (*p*=0.000)High pocket money group47.4%46.5%32.7%WP vs NS (*p*=0.003)\
CS vs NS (*p*=0.000)[^2]

Respiratory symptoms {#S0003-S2002}
--------------------

The average number of respiratory symptoms experienced was 5.1 (standard deviation 3.5), 5.8 (standard deviation 3.5), and 2.9 (standard deviation 2.8), in WP smokers, cigarette smokers, and non-smokers, respectively. The two groups of smokers reported a comparable number of respiratory symptoms, and both values were significantly higher than that reported for non-smokers. [Figure 1](#F0001){ref-type="fig"} provides a display of the proportions of subjects reporting each respiratory symptom across WP smokers, cigarette smokers and non-smokers. Non-smokers were significantly less likely to report any of the measured respiratory symptoms. When bivariate comparisons were limited to WP and cigarette smokers, a significantly higher proportion of cigarette smokers than WP smokers reported cough upon waking and phlegm upon waking. WP and cigarette smokers were otherwise comparable across other respiratory symptoms.Figure 1Proportions reporting each respiratory symptom across waterpipe smokers (WP), cigarette smokers (CS), and non-smokers (NS).**Notes:** Please see separate image. \*p-value for chi-square statistic comparing waterpipe smokers to non-smokers or cigarette smokers to non-smokers \<0.015 (significance cut-off for Šidák-Holm adjusted *p*-value). ^¶^p-value for chi-square statistic comparing waterpipe smokers to cigarette smokers \<0.015. ^§^p-value for chi-square statistic comparing waterpipe smokers to cigarette smokers \<0.05 but \>0.015. ^ǂ^p-value for chi-square statistic comparing cigarette smokers to non-smokers \<0.016; p-value for chi-square statistic comparing waterpipe smokers to non-smokers \<0.05 but \>0.016.

In multivariable regression analysis of number of respiratory symptoms reported by each group, controlling for other variables that may have impacted respiratory health, both WP and cigarette smokers continued to exhibit a significantly higher number of respiratory symptoms than non-smokers ([Table 3](#T0003){ref-type="table"}). Specifically, after multivariable adjustment (for exposure to secondhand smoke, exposure to censer smoke, living near a factory, being overweight or obese, and engaging in regular physical activity), WP smokers compared to non-smokers had a 1.6 times greater rate of respiratory symptoms (95% confidence interval 1.4--1.9); while cigarette smokers compared to non-smokers had a 1.9 times greater rate of respiratory symptoms (95% confidence interval 1.7--2.2). Although the rate of respiratory symptoms was lower among WP smokers than cigarette smokers, it was not statistically different between the two tobacco groups.Table 3Multivariable negative binomial regression model of count of respiratory symptoms in waterpipe smokers (WP), cigarette smokers (CS) compared to non-smokers (incidence rate ratios presented)Incidence rate ratio(95% confidence interval)Smoking status Non-smokerReference group (1.0) Waterpipe smokers\*1.6 (1.4--1.9) Cigarette smokers1.9 (1.7--2.2)Daily second hand smoking exposure (versus less than daily)\*1.2 (1.1--1.4)Daily censer smoke exposure (versus less than daily)1.1 (0.95--1.4)Living near a factory (versus not living near one)\*1.3 (1.1--1.6)Being overweight or obese(versus having a BMI \<25)1.1 (0.93--1.2)Active lifestyle (versus not performing regular exercise)\*0.88 (0.78--0.99)[^3]

Additional multivariate logistic regressions were run to measure the likelihood of reporting cough and phlegm, two respiratory-specific symptoms of importance,[@CIT0002],[@CIT0011] across the three groups. The likelihood of reporting cough and phlegm ("usually present during night or day") were significantly higher in both WP and cigarette smokers (than in non-smokers), but comparable statistically between the two groups of smokers. However, cigarette smokers were significantly more likely (than either non-smokers or WP smokers) to report cough or phlegm upon waking, and to report an episode of cough with phlegm that lasted at least 3 weeks.

Quality of life {#S0003-S2003}
---------------

Non-smokers reported significantly higher scores for general health relative to either WP or cigarette smokers, and significantly higher physical health scores relative to only cigarette smokers. Cigarette smokers also displayed the worst scores for the physical limitations domain (significantly lower than either WP smokers or non-smokers). Conversely, non-smokers reported the lowest score on the emotional limitations domain, which reached significance only when comparing WP smokers to non-smokers ([Table 4](#T0004){ref-type="table"}). No other significant differences were observed among other quality of life domains.Table 4Quality of life mean scores reported by waterpipe smokers (WP), cigarette smokers (CS) and non-smokers (NS)Waterpipe smokers (N=135)Cigarette smokers (N=303)Non-smokers (N=300)Pairwise comparisons\* ¶General health: mean(median, standard deviation)61.8 (62.5, 25.4)57.0 (50.0, 28.3)68.1 (75.0, 25.1)CS vs NS (*p*=0.0001)\
WP vs NS (*p*=0.0127)\
WP vs CS (*p*=0.085)Physical health: mean(median, standard deviation)65.6 (75.0, 32.9)61.6 (75.0, 32.1)69.9 (75.0, 31.9)CS vs NS (*p*=0.0007)\
WP vs NS (*p*=0.180)Social health: mean(median, standard deviation)69.7 (75.0, 30.9)67.6 (75.0, 29.9)69.6 (75.0, 29.0)No significant overall difference (*p*=0.610)Mental health: mean(median, standard deviation)62.1 (60.0, 19.6)58.0 (60.0, 21.7)59.9 (60.0, 20.7)No significant overall difference (*p*=0.290)Emotional limitations: mean(median, standard deviation)60.9 (100, 44.1)54.1 (50.0, 43.1)48.4 (50.0, 45.1)WP vs NS (*p*=0.007)\
WP vs CS (*p*=0.140)\
CS vs NS (*p*=0.123)Physical limitations: mean(median, standard deviation)69.0 (100, 41.5)59.5 (50.0, 42.6)68.0 (100, 42.3)CS vs WP (*p*=0.023)\
CS vs NS (*p*=0.008)Vitality: mean (median, standard deviation)56.6 (60.0, 26.4)56.6 (60.0, 27.0)56.4 (60.0, 24.6)No significant overall difference (*p*=0.993)Pain: mean (median, standard deviation)79.7 (75.0, 21.8)77.9 (75.0, 22.4)79.2 (75.0, 23.2)No significant overall difference (*p*=0.570)[^4]

Discussion {#S0004}
==========

Our study aimed to determine the early respiratory health effects of habitual WP smoking lasting at least three years, using both non-smokers and cigarette smokers as reference groups. The study is unique in that -- by virtue of its regional scope -- it was adequately sized for statistical comparisons, and addressed both respiratory and quality of life outcomes while adjusting for other lifestyle-related confounders. Using measures that have been found to be important signals of potential pulmonary disease (respiratory symptoms),[@CIT0002],[@CIT0011],[@CIT0012],[@CIT0043] we found that WP smoking was comparable in its direction and overall extent of damage to cigarette smoking. This finding is consistent with what we know of the respiratory toxicity profile of both cigarettes and WP;[@CIT0006],[@CIT0010] and can be used to directly address the fallacies among youth and young adults that WP smoking is relatively harmless to them, and that respiratory damage at a young age is unlikely.[@CIT0025],[@CIT0044]--[@CIT0048]

Our interest in respiratory symptoms as a measurable outcome is important to emphasize. Increasingly, there has been a shift in focus from spirometric measures that have conventionally been used to detect the onset of respiratory disease. This is because studies are demonstrating, through clinical \[respiratory\] symptoms, that disease may be underway even before significant changes in spirometry are detected. And while these studies have been conducted in relatively older cigarette-smoking adults who are being managed as COPD patients,[@CIT0012],[@CIT0049] the prevalence estimates for specific respiratory symptoms in our young sample are not far in value from those reported in these studies. This in turn highlights the dire health situation at hand with young habitual WP and cigarette smokers.

Our data demonstrated that, with regards to respiratory health, both types of smoking induced significantly alarming symptoms in comparison to non-smokers. The overall number of respiratory symptoms reported by both groups of smokers was significantly higher than in non-smokers (and not significantly different between the two groups of smokers). Comparable proportions of both groups of smokers reported specific respiratory symptoms (wheezing, shortness of breath, cough or phlegm usually present at any time, a cold that goes to the chest, and a chest illness that kept one in bed); and both proportions (reported in WP and cigarette smokers) were significantly higher than those in non-smokers. Not surprisingly, both groups of smokers also reported significantly lower general health scores than non-smokers.

There were a few respiratory symptoms that were observed to be significantly more frequent in cigarette smokers than WP smokers (and cigarette smokers fared worse in physical quality of life aspects). Such differences may be due to more than one reason. Cigarette smokers in our sample initiated smoking at a younger age (borderline significance), and a substantial proportion of them (40%) smoked a pack or more daily. Furthermore, roughly 28% of WP smokers smoked seven or more times a week, indicating the latter were not exposed on a daily basis to tobacco smoke in the same way cigarette smokers were. In addition, about 67% of WP smokers tended to share their WP, which is likely to attenuate exposure. There also are inherent differences between cigarettes and WPs (for example they differ in accessibility and ease of assembly, rendering the cigarette more likely to be used more frequently on a daily basis). Finally, while both cigarette and WP smoke contain toxic chemicals, the exact mix and concentration of these chemicals differs between the two.[@CIT0006],[@CIT0007] It is therefore not unusual that, while both WP smoking and cigarette smoking induce serious respiratory damage, the trajectory of harm may differ between them.

There were other findings in our study that warrant concern with regards to WP use. Although WP and cigarette smokers exhibited comparable harms, WP users were less likely to attempt to quit, and substantially less WP users expressed intention to quit within the next month or the next six months. There also were differences in the brief measures of perceived harm that we used. No more than roughly a quarter of the entire sample believed WP and cigarette smoking were similarly harmful (while more cigarette and non-smokers than WP smokers believed WP to be more harmful). Furthermore, although the association between smoking and weight gain is a multifactorial and variable one which takes decades to unfold,[@CIT0050] it is noteworthy that, similar to other findings,[@CIT0051] our sample of WP smokers, even at a younger age, had a significantly higher BMI than non-smokers. Cigarette smokers also had a significantly higher BMI than non-smokers. It is unclear if tobacco use may be associated with a lifestyle that leads to a higher BMI (tobacco users in our sample were more likely to consume sugary foods on a daily basis), or if those who perceive themselves to be overweight resort to tobacco use to try to lose weight. Nevertheless, our findings are relevant because they indicate that, in addition to respiratory harms, WP use in young adults is associated with other unhealthy lifestyle factors.

With regards to quality of life, differences in prevalence of respiratory symptoms translated only to differences in overall quality of life scores. With regards to mental health, WP smokers reported the highest scores with regards to "emotional limitations", followed by cigarette smokers. This is inconsistent with what other studies have found.[@CIT0020]--[@CIT0022] We speculate that our sample of tobacco users may rely heavily on smoking as a form of coping, and that tobacco use is associated with a more social lifestyle that may facilitate emotional functionality in Middle Eastern young adults. Youth have reported WP use as an alternative recreational activity, or as a means to relax, to address loneliness and boredom, to socialize, or to experience a positive somatic effect.[@CIT0052] It is therefore possible that achieving this produces the higher scores for emotional well-being we observe in our sample of young Middle Eastern users.

Our study has some limitations. We employed purposive rather than random sampling, due to logistic constraints. Nevertheless, we ensured that data collectors frequented gathering sites across university campuses (rather than focus on only a few locations). We also did not track the number of screened subjects who refused or were ineligible to participate. In addition, the cross-sectional nature of our study design made it difficult to ascertain the temporal nature of damage induced by smoking. Finally, although the direction of effects trended similarly within countries, inter-country variability in effect size is possible. However, the study was not powered to detect differences between countries. Rather, it used a regional scope to ensure that a sufficient number of habitual WP users could be recruited.

In summary, our study contributes uniquely to the literature on WP health effects by focusing on respiratory and quality of life measures in a relatively homogenous (in terms of tobacco use) and sufficiently sized sample of young WP users. Despite their age, we found that regular exclusive WP smokers and regular exclusive cigarette smokers reported significantly greater \[than non-smokers\] respiratory symptoms such as cough and phlegm, early symptoms of respiratory disease.

Conclusion {#S0005}
==========

Relative to their young non-smoking counterparts, young habitual WP smokers exhibit a significant burden of respiratory symptoms that is comparable to that observed with cigarette smokers. Young WP smokers (and cigarette smokers), despite their age, may be well on their way to developing respiratory disease.
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[^1]: **Note:** \*Significance cut-off for Šidák-Holm adjusted *p*-value \<0.004.

[^2]: **Notes: ^¶^**Defined as performing strenuous exercise atleast 2 to 3 times weekly, for a weekly total of atleast 2 to 3 hrs. \*Significance cut-off for Šidák-Holm adjusted *p*-value \<0.004.

[^3]: **Note:** \*Incidence rate ratio (95% confidence interval) for waterpipe smokers when using positive controls (cigarette smokers) as the reference group: 0.87 (0.75--1.0).

[^4]: **Notes:** \*Pairwise ANOVA (if normally distributed) or medians/rank-sum (if failing the normality assumption). ^¶^Significance cut-off for Šidák-Holm adjusted *p*-value \<0.008.
